Results 181 to 190 of about 6,016 (195)

CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer

Breast Cancer Research and Treatment, 1995
This is the first comparison of the three mucin based tests CA15-3, CASA, and MSA, and the cytokeratin-related TPS assay in breast cancer. The mucin markers were superior to TPS in receiver-operator analysis, though no marker was of use in the diagnosis of malignancy due to low sensitivity. Using cutpoints that gave 95% specificity in benign disease (n
DEVINE, PL, DUROUX, MA, QUIN, RJ, MCGUCKIN, MA, JOY, GJ, WARD, BG, POLLARD, CW   +6 more
openaire   +3 more sources

Comparison of serum CA15-3 and CEA in breast cancer.

Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences, 1996
The monoclonal antibodies CA15-3 were developed against the two antigens 115D8 of the human milk fat globule membrane and DF3 of breast cancer. CA15-3 was assayed radioimmunologically and CEA was analysed using the enzyme immunoassay. Normal control was achieved in 32 healthy women, the mean values for CA15-3 were 11.5 +/- 3.0 u/ml, range from 7.9 to ...
M F, Hou, T J, Huang, J S, Hsieh, Y S, Huang, C J, Huang, H M, Chan, J Y, Wang, Y L, Chen, S B, Jong, C C, Yang   +9 more
openaire   +1 more source

[CA15-3 tumor marker in early detection of breast cancer].

Harefuah, 1992
CA15-3 is a tumor marker associated with mammary tumors. Increased levels have been observed in patients with breast cancer, while normal low levels are usually found in women with no evidence of disease. The potential clinical uses of this marker include monitoring of patients with breast cancer, prognosis, and early detection of recurrence.
I, Roisman, E, Shiloni, I, Lifshiz, D, Shoshani, D, Saphir, I, Honigman, N, Livni, Y, Sherman, O, Papo, A L, Durst   +9 more
openaire   +1 more source

ความสัมพันธ์ระหว่างผลตรวจยีน BRCA กับ CA15-3 และ CA 125 ในผู้ป่วยโรงพยาบาลสวรรค์ประชารักษ์

วารสารวิชาการแพทย์และสาธารณสุข เขตสุขภาพที่ 3, 22, 1, 9 ...
openaire   +1 more source

Comparative Prognostic Significance of CEA and CA15-3 in Breast Cancer

International Journal of Advanced Pharmaceutical Sciences and Research
Breast cancer is a leading cause of cancer-related mortality worldwide, particularly among women. Thus, it is critical to have reliable biomarkers for prognosis and metastasis detection. This retrospective study compared the prognostic utility of serum tumour markers CEA and CA15-3 in 117 female breast cancer patients admitted to Lattakia University ...
Riham Mohammad Aljouji, Dr. Issa Radwan Yusuf, Dr. Rama Hussein Ibrahim   +2 more
openaire   +1 more source

[Immunoradiometric assay of tumor marker CA15-3 and its clinical application].

Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000
To develop a new tumor marker immunoradiometric assay and to evaluate its preliminary clinical application.With monoclonal antibodies Ma552 and Ma695 from Sweden, a sandwich immunoradiometric assay was developed with Ma552 as catching antibody and Ma695 as tracer. The Ma552 was coated on polystyrene beads, and Ma695 was labeled with 125-I. The reaction
Z, Chen, Z, Fan, J, Yang
openaire   +1 more source

Elevation of CA15-3 caused by a benign tumour

The Lancet Oncology, 2001
J P, Ghnassia, J F, Rodier, M, Eber
openaire   +2 more sources

[CA15-3].

Nihon rinsho. Japanese journal of clinical medicine, 2011
openaire   +3 more sources

CA15-3 and Related Antigens as Serum Markers for Monitoring Breast Cancer

1988
Tumor-associated antigens which circulate in the serum of breast cancer patients have been studied as markers for monitoring clinical course. Many circulating antigens, including casein (1), alpha-lactalbumin (2), ceruloplasmin (3), creatinine kinase (4), sialyltransferases (5, 6), glycolipids (7), phospholipids (8) and gross cystic disease protein (9)
D. W. Kufe, D. Hayes, M. Abe, T. Ohno
openaire   +1 more source

[CA15-3].

Nihon rinsho. Japanese journal of clinical medicine, 2000
A, Matsui, T, Ikeda, S, Masamura, M, Kitajima   +3 more
openaire   +1 more source